Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 9.30289466 |
2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.35654984 |
3 | epoxygenase P450 pathway (GO:0019373) | 8.29602786 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.59709011 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.59709011 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.25657236 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25657236 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.82730050 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.34234256 |
10 | tryptophan catabolic process (GO:0006569) | 6.17481217 |
11 | indole-containing compound catabolic process (GO:0042436) | 6.17481217 |
12 | indolalkylamine catabolic process (GO:0046218) | 6.17481217 |
13 | kynurenine metabolic process (GO:0070189) | 6.05147964 |
14 | drug metabolic process (GO:0017144) | 5.99425090 |
15 | bile acid biosynthetic process (GO:0006699) | 5.98750641 |
16 | oxidative demethylation (GO:0070989) | 5.81612487 |
17 | tryptophan metabolic process (GO:0006568) | 5.81004000 |
18 | glyoxylate metabolic process (GO:0046487) | 5.80613021 |
19 | negative regulation of fibrinolysis (GO:0051918) | 5.73870277 |
20 | urea metabolic process (GO:0019627) | 5.70718428 |
21 | urea cycle (GO:0000050) | 5.70718428 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.60030388 |
23 | regulation of plasminogen activation (GO:0010755) | 5.59802579 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58113721 |
25 | regulation of fibrinolysis (GO:0051917) | 5.55029663 |
26 | complement activation, alternative pathway (GO:0006957) | 5.51493149 |
27 | regulation of protein activation cascade (GO:2000257) | 5.50747447 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.47327639 |
29 | protein carboxylation (GO:0018214) | 5.47327639 |
30 | cysteine metabolic process (GO:0006534) | 5.37361371 |
31 | sulfur amino acid catabolic process (GO:0000098) | 5.35277904 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.24426187 |
33 | ethanol metabolic process (GO:0006067) | 5.17958574 |
34 | serine family amino acid catabolic process (GO:0009071) | 5.13615177 |
35 | regulation of complement activation (GO:0030449) | 5.13366461 |
36 | bile acid metabolic process (GO:0008206) | 5.12007129 |
37 | phenylpropanoid metabolic process (GO:0009698) | 4.98614635 |
38 | aromatic amino acid family metabolic process (GO:0009072) | 4.95755024 |
39 | reverse cholesterol transport (GO:0043691) | 4.90878673 |
40 | negative regulation of hemostasis (GO:1900047) | 4.88936650 |
41 | negative regulation of blood coagulation (GO:0030195) | 4.88936650 |
42 | regulation of cholesterol esterification (GO:0010872) | 4.86743437 |
43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86163027 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.82218651 |
45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81189474 |
46 | protein-lipid complex remodeling (GO:0034368) | 4.81189474 |
47 | macromolecular complex remodeling (GO:0034367) | 4.81189474 |
48 | tyrosine metabolic process (GO:0006570) | 4.81105101 |
49 | homocysteine metabolic process (GO:0050667) | 4.79070235 |
50 | regulation of humoral immune response (GO:0002920) | 4.77319256 |
51 | S-adenosylmethionine metabolic process (GO:0046500) | 4.67891678 |
52 | triglyceride homeostasis (GO:0070328) | 4.64907997 |
53 | acylglycerol homeostasis (GO:0055090) | 4.64907997 |
54 | alpha-amino acid catabolic process (GO:1901606) | 4.64247107 |
55 | amino-acid betaine metabolic process (GO:0006577) | 4.57512395 |
56 | phospholipid efflux (GO:0033700) | 4.56823246 |
57 | lysine catabolic process (GO:0006554) | 4.55646076 |
58 | lysine metabolic process (GO:0006553) | 4.55646076 |
59 | negative regulation of sterol transport (GO:0032372) | 4.54027317 |
60 | negative regulation of cholesterol transport (GO:0032375) | 4.54027317 |
61 | negative regulation of protein activation cascade (GO:2000258) | 4.50425752 |
62 | cellular ketone body metabolic process (GO:0046950) | 4.45620036 |
63 | negative regulation of coagulation (GO:0050819) | 4.44106831 |
64 | glycine metabolic process (GO:0006544) | 4.44071497 |
65 | bile acid and bile salt transport (GO:0015721) | 4.43820853 |
66 | plasma lipoprotein particle clearance (GO:0034381) | 4.42025269 |
67 | imidazole-containing compound metabolic process (GO:0052803) | 4.40382377 |
68 | coenzyme catabolic process (GO:0009109) | 4.39643507 |
69 | negative regulation of wound healing (GO:0061045) | 4.39523849 |
70 | positive regulation of hemostasis (GO:1900048) | 4.38700509 |
71 | positive regulation of blood coagulation (GO:0030194) | 4.38700509 |
72 | indolalkylamine metabolic process (GO:0006586) | 4.37506057 |
73 | alkaloid metabolic process (GO:0009820) | 4.28144002 |
74 | cellular biogenic amine catabolic process (GO:0042402) | 4.27979224 |
75 | amine catabolic process (GO:0009310) | 4.27979224 |
76 | cellular amino acid catabolic process (GO:0009063) | 4.26476058 |
77 | glutamate metabolic process (GO:0006536) | 4.26454987 |
78 | cholesterol efflux (GO:0033344) | 4.26078354 |
79 | cellular glucuronidation (GO:0052695) | 4.24454238 |
80 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.20352473 |
81 | serine family amino acid metabolic process (GO:0009069) | 4.18164382 |
82 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.15713114 |
83 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.15713114 |
84 | benzene-containing compound metabolic process (GO:0042537) | 4.10472070 |
85 | fibrinolysis (GO:0042730) | 4.09354735 |
86 | ethanol oxidation (GO:0006069) | 4.07628201 |
87 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06839468 |
88 | cellular modified amino acid catabolic process (GO:0042219) | 4.06443057 |
89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.03886958 |
90 | plasma lipoprotein particle assembly (GO:0034377) | 4.03171674 |
91 | positive regulation of coagulation (GO:0050820) | 4.02915088 |
92 | arginine metabolic process (GO:0006525) | 4.02507263 |
93 | serine family amino acid biosynthetic process (GO:0009070) | 4.02366607 |
94 | aldehyde catabolic process (GO:0046185) | 3.99974171 |
95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.94882041 |
96 | complement activation, classical pathway (GO:0006958) | 3.86213910 |
97 | ketone body metabolic process (GO:1902224) | 3.85746134 |
98 | drug catabolic process (GO:0042737) | 3.84310687 |
99 | complement activation (GO:0006956) | 3.82371273 |
100 | protein activation cascade (GO:0072376) | 3.81783479 |
101 | cofactor catabolic process (GO:0051187) | 3.81136371 |
102 | intestinal cholesterol absorption (GO:0030299) | 3.80477987 |
103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79682810 |
104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79682810 |
105 | phospholipid homeostasis (GO:0055091) | 3.77691441 |
106 | glucuronate metabolic process (GO:0019585) | 3.76373346 |
107 | uronic acid metabolic process (GO:0006063) | 3.76373346 |
108 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75972293 |
109 | cholesterol homeostasis (GO:0042632) | 3.75898360 |
110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.75073888 |
111 | cytolysis (GO:0019835) | 3.73351503 |
112 | positive regulation of lipid catabolic process (GO:0050996) | 3.72690755 |
113 | negative regulation of lipase activity (GO:0060192) | 3.72177189 |
114 | organic acid catabolic process (GO:0016054) | 3.72089292 |
115 | carboxylic acid catabolic process (GO:0046395) | 3.72089292 |
116 | flavonoid metabolic process (GO:0009812) | 3.70082818 |
117 | sterol homeostasis (GO:0055092) | 3.69601707 |
118 | regulation of cholesterol homeostasis (GO:2000188) | 3.67068138 |
119 | regulation of apoptotic cell clearance (GO:2000425) | 3.66449600 |
120 | plasma lipoprotein particle organization (GO:0071827) | 3.65769662 |
121 | hormone catabolic process (GO:0042447) | 3.64845161 |
122 | acetyl-CoA metabolic process (GO:0006084) | 3.64577944 |
123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.64110907 |
124 | negative regulation of complement activation (GO:0045916) | 3.61905707 |
125 | protein-lipid complex assembly (GO:0065005) | 3.61232507 |
126 | short-chain fatty acid metabolic process (GO:0046459) | 3.60533565 |
127 | acute inflammatory response (GO:0002526) | 3.60200250 |
128 | opsonization (GO:0008228) | 3.58844421 |
129 | acute-phase response (GO:0006953) | 3.56958132 |
130 | heme transport (GO:0015886) | 3.56864170 |
131 | response to mercury ion (GO:0046689) | 3.55933502 |
132 | regulation of lipoprotein particle clearance (GO:0010984) | 3.52095706 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39908072 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19644563 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.01726680 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53166557 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32612549 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16086194 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79234641 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07934481 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05654652 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07094462 |
11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9682742 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97479219 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92723899 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62462952 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.57733686 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53763230 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44988766 |
18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40978089 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31204518 |
20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23647664 |
21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20657085 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17822766 |
23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12037287 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10045062 |
25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02618735 |
26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00751949 |
27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93780070 |
28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91551671 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86232247 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86169638 |
31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84516016 |
32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83842633 |
33 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83247746 |
34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81648323 |
35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79540709 |
36 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.77394398 |
37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77192578 |
38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76817473 |
39 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76667760 |
40 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76037048 |
41 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75111524 |
42 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.74765036 |
43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74112675 |
44 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74039582 |
45 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74025160 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72596839 |
47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69778028 |
48 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.68907470 |
49 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68557209 |
50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67683412 |
51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67403551 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66291924 |
53 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.65551528 |
54 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65262587 |
55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65086600 |
56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65086600 |
57 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.64974657 |
58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64405409 |
59 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63903962 |
60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62678256 |
61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62323910 |
62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60916050 |
63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.60666700 |
64 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.60618333 |
65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60387906 |
66 | NFYA_21822215_ChIP-Seq_K562_Human | 0.60179024 |
67 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59800988 |
68 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59127730 |
69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57862420 |
70 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57112717 |
71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56887779 |
72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.56440008 |
73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.55733853 |
74 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.54843592 |
75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54003488 |
76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.53625478 |
77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53547561 |
78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53534727 |
79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.53501953 |
80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53500154 |
81 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.53495219 |
82 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.53348814 |
83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53212583 |
84 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.52755260 |
85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.52209293 |
86 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52091477 |
87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.51651985 |
88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51615767 |
89 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51583964 |
90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.51484730 |
91 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51399810 |
92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51086213 |
93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.50806797 |
94 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50777105 |
95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.49834644 |
96 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.49821098 |
97 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.49386575 |
98 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48589283 |
99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48565112 |
100 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.48418228 |
101 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47814440 |
102 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.47661504 |
103 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47093761 |
104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.46614855 |
105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.46419972 |
106 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46369075 |
107 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46350717 |
108 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.46328402 |
109 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.45967743 |
110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45102680 |
111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44832295 |
112 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44029405 |
113 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43882519 |
114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43868231 |
115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42512603 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42361853 |
117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42143160 |
118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42054041 |
119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41048902 |
120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40929768 |
121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40215542 |
122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40129393 |
123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40095822 |
124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39726001 |
125 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39533060 |
126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38931979 |
127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38513337 |
128 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38213473 |
129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38031101 |
130 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35704564 |
131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35307433 |
132 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35083774 |
133 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.34180397 |
134 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33537089 |
135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33434506 |
136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33411491 |
137 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33363243 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.29573663 |
2 | MP0005360_urolithiasis | 7.55690011 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.46732829 |
4 | MP0005365_abnormal_bile_salt | 6.15697657 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.08782475 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.27929146 |
7 | MP0003252_abnormal_bile_duct | 3.91368093 |
8 | MP0010329_abnormal_lipoprotein_level | 3.61166476 |
9 | MP0009840_abnormal_foam_cell | 3.29607915 |
10 | MP0005083_abnormal_biliary_tract | 3.13889406 |
11 | MP0003195_calcinosis | 2.86817000 |
12 | MP0005332_abnormal_amino_acid | 2.73771860 |
13 | MP0001666_abnormal_nutrient_absorption | 2.59650187 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.39072709 |
15 | MP0000609_abnormal_liver_physiology | 2.17412648 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.11906278 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.10206853 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.96238224 |
19 | MP0003868_abnormal_feces_composition | 1.92897657 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82502707 |
21 | MP0001764_abnormal_homeostasis | 1.65593160 |
22 | MP0009697_abnormal_copulation | 1.60605223 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56560043 |
24 | MP0003011_delayed_dark_adaptation | 1.41216080 |
25 | MP0005451_abnormal_body_composition | 1.40011598 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.27607192 |
27 | MP0003186_abnormal_redox_activity | 1.24525036 |
28 | MP0009643_abnormal_urine_homeostasis | 1.21170640 |
29 | MP0000598_abnormal_liver_morphology | 1.18526417 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.17620034 |
31 | MP0005647_abnormal_sex_gland | 1.15113751 |
32 | MP0000604_amyloidosis | 1.10875057 |
33 | MP0009764_decreased_sensitivity_to | 1.06057578 |
34 | MP0002254_reproductive_system_inflammat | 1.05882252 |
35 | MP0009763_increased_sensitivity_to | 1.03394081 |
36 | MP0010368_abnormal_lymphatic_system | 1.01463316 |
37 | MP0005636_abnormal_mineral_homeostasis | 0.91851031 |
38 | MP0008469_abnormal_protein_level | 0.89706069 |
39 | MP0009642_abnormal_blood_homeostasis | 0.87244910 |
40 | MP0001915_intracranial_hemorrhage | 0.84635541 |
41 | MP0005408_hypopigmentation | 0.84506116 |
42 | MP0002282_abnormal_trachea_morphology | 0.82295621 |
43 | MP0006036_abnormal_mitochondrial_physio | 0.79938242 |
44 | MP0005376_homeostasis/metabolism_phenot | 0.79418652 |
45 | MP0009765_abnormal_xenobiotic_induced | 0.78473285 |
46 | MP0002078_abnormal_glucose_homeostasis | 0.77870426 |
47 | MP0005670_abnormal_white_adipose | 0.76468655 |
48 | MP0005084_abnormal_gallbladder_morpholo | 0.76168629 |
49 | MP0002876_abnormal_thyroid_physiology | 0.75836327 |
50 | MP0005220_abnormal_exocrine_pancreas | 0.74887369 |
51 | MP0002971_abnormal_brown_adipose | 0.72202084 |
52 | MP0003879_abnormal_hair_cell | 0.71501273 |
53 | MP0005187_abnormal_penis_morphology | 0.70716304 |
54 | MP0001661_extended_life_span | 0.69772199 |
55 | MP0005334_abnormal_fat_pad | 0.68562340 |
56 | MP0002249_abnormal_larynx_morphology | 0.68375482 |
57 | MP0003690_abnormal_glial_cell | 0.68269566 |
58 | MP0004130_abnormal_muscle_cell | 0.68213734 |
59 | MP0005535_abnormal_body_temperature | 0.66897997 |
60 | MP0009053_abnormal_anal_canal | 0.66283951 |
61 | MP0005266_abnormal_metabolism | 0.63738134 |
62 | MP0003329_amyloid_beta_deposits | 0.63214846 |
63 | MP0000639_abnormal_adrenal_gland | 0.61946966 |
64 | MP0001756_abnormal_urination | 0.56579451 |
65 | MP0006035_abnormal_mitochondrial_morpho | 0.56123078 |
66 | MP0005464_abnormal_platelet_physiology | 0.55776926 |
67 | MP0005448_abnormal_energy_balance | 0.55681545 |
68 | MP0009785_altered_susceptibility_to | 0.53062976 |
69 | MP0005023_abnormal_wound_healing | 0.52164593 |
70 | MP0005395_other_phenotype | 0.49162838 |
71 | MP0002822_catalepsy | 0.48920651 |
72 | MP0002928_abnormal_bile_duct | 0.46175885 |
73 | MP0003638_abnormal_response/metabolism_ | 0.45915934 |
74 | MP0003718_maternal_effect | 0.45552874 |
75 | MP0003436_decreased_susceptibility_to | 0.45472736 |
76 | MP0003724_increased_susceptibility_to | 0.45045744 |
77 | MP0008874_decreased_physiological_sensi | 0.44811780 |
78 | MP0008873_increased_physiological_sensi | 0.44153798 |
79 | MP0002136_abnormal_kidney_physiology | 0.43662832 |
80 | MP0004782_abnormal_surfactant_physiolog | 0.43008424 |
81 | MP0003075_altered_response_to | 0.41904715 |
82 | MP0000566_synostosis | 0.41779658 |
83 | MP0002837_dystrophic_cardiac_calcinosis | 0.40994774 |
84 | MP0005058_abnormal_lysosome_morphology | 0.40767063 |
85 | MP0003953_abnormal_hormone_level | 0.40439743 |
86 | MP0005248_abnormal_Harderian_gland | 0.40175193 |
87 | MP0005166_decreased_susceptibility_to | 0.39517591 |
88 | MP0004381_abnormal_hair_follicle | 0.39375208 |
89 | MP0009672_abnormal_birth_weight | 0.36849260 |
90 | MP0000579_abnormal_nail_morphology | 0.36773590 |
91 | MP0005666_abnormal_adipose_tissue | 0.35489989 |
92 | MP0008872_abnormal_physiological_respon | 0.35435494 |
93 | MP0000467_abnormal_esophagus_morphology | 0.34906578 |
94 | MP0009384_cardiac_valve_regurgitation | 0.34399821 |
95 | MP0000249_abnormal_blood_vessel | 0.32989686 |
96 | MP0006082_CNS_inflammation | 0.32665934 |
97 | MP0004883_abnormal_blood_vessel | 0.32438486 |
98 | MP0002796_impaired_skin_barrier | 0.32211898 |
99 | MP0009115_abnormal_fat_cell | 0.31918241 |
100 | MP0001243_abnormal_dermal_layer | 0.31810567 |
101 | MP0002168_other_aberrant_phenotype | 0.30828453 |
102 | MP0000230_abnormal_systemic_arterial | 0.30498436 |
103 | MP0002970_abnormal_white_adipose | 0.30211662 |
104 | MP0001851_eye_inflammation | 0.29297472 |
105 | MP0001853_heart_inflammation | 0.29159335 |
106 | MP0001845_abnormal_inflammatory_respons | 0.28217496 |
107 | MP0001881_abnormal_mammary_gland | 0.28163489 |
108 | MP0005164_abnormal_response_to | 0.25959243 |
109 | MP0002132_abnormal_respiratory_system | 0.25611559 |
110 | MP0005397_hematopoietic_system_phenotyp | 0.23948561 |
111 | MP0001545_abnormal_hematopoietic_system | 0.23948561 |
112 | MP0002060_abnormal_skin_morphology | 0.23491015 |
113 | MP0000427_abnormal_hair_cycle | 0.23241804 |
114 | MP0003632_abnormal_nervous_system | 0.19058416 |
115 | MP0002128_abnormal_blood_circulation | 0.18905933 |
116 | MP0005197_abnormal_uvea_morphology | 0.18801898 |
117 | MP0002332_abnormal_exercise_endurance | 0.17911025 |
118 | MP0001986_abnormal_taste_sensitivity | 0.17656771 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.53788548 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.38468317 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.37138022 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.72316369 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.66139777 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.45260767 |
7 | Xanthomatosis (HP:0000991) | 6.30073326 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.59579113 |
9 | Complement deficiency (HP:0004431) | 5.55877065 |
10 | Joint hemorrhage (HP:0005261) | 4.91157363 |
11 | Hypolipoproteinemia (HP:0010981) | 4.84023811 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.61879769 |
13 | Hyperammonemia (HP:0001987) | 4.57381305 |
14 | Epidermoid cyst (HP:0200040) | 4.54168272 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42644864 |
16 | Hyperglycinemia (HP:0002154) | 4.40770739 |
17 | Abnormality of methionine metabolism (HP:0010901) | 4.25655426 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 4.23486433 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.22875667 |
20 | Ketosis (HP:0001946) | 4.20942427 |
21 | Fat malabsorption (HP:0002630) | 4.15574557 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.10307667 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08930400 |
24 | Abnormality of complement system (HP:0005339) | 4.05973345 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.86687073 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86687073 |
27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85940855 |
28 | Hyperglycinuria (HP:0003108) | 3.85321317 |
29 | Hypoglycemic coma (HP:0001325) | 3.83051311 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80955747 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.75869764 |
32 | Hypercholesterolemia (HP:0003124) | 3.64268811 |
33 | Hyperbilirubinemia (HP:0002904) | 3.34018593 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31309063 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26955234 |
36 | Spontaneous abortion (HP:0005268) | 3.21594160 |
37 | Steatorrhea (HP:0002570) | 3.11435919 |
38 | Delayed CNS myelination (HP:0002188) | 3.07317166 |
39 | Abnormality of serum amino acid levels (HP:0003112) | 3.04096229 |
40 | Hypochromic microcytic anemia (HP:0004840) | 3.02986081 |
41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02546484 |
42 | Hepatocellular carcinoma (HP:0001402) | 3.00124796 |
43 | Myocardial infarction (HP:0001658) | 3.00122700 |
44 | Ketoacidosis (HP:0001993) | 2.96941494 |
45 | Skin nodule (HP:0200036) | 2.81689650 |
46 | Systemic lupus erythematosus (HP:0002725) | 2.80600530 |
47 | Metabolic acidosis (HP:0001942) | 2.72063845 |
48 | Purpura (HP:0000979) | 2.67317750 |
49 | Acanthocytosis (HP:0001927) | 2.63463226 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.63341853 |
51 | Vascular calcification (HP:0004934) | 2.57547855 |
52 | Lethargy (HP:0001254) | 2.56258710 |
53 | Glomerulonephritis (HP:0000099) | 2.55721715 |
54 | Osteomalacia (HP:0002749) | 2.52039810 |
55 | Dicarboxylic aciduria (HP:0003215) | 2.51944714 |
56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51944714 |
57 | Abnormal gallbladder morphology (HP:0012437) | 2.48789864 |
58 | Hypoglycemic seizures (HP:0002173) | 2.48363926 |
59 | Spastic diplegia (HP:0001264) | 2.44539424 |
60 | Mitral stenosis (HP:0001718) | 2.43798769 |
61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43644932 |
62 | Cholelithiasis (HP:0001081) | 2.42286484 |
63 | Gout (HP:0001997) | 2.41765377 |
64 | Pulmonary embolism (HP:0002204) | 2.41426382 |
65 | Cerebral edema (HP:0002181) | 2.38130511 |
66 | Amyloidosis (HP:0011034) | 2.37938995 |
67 | Cholecystitis (HP:0001082) | 2.36086442 |
68 | Abnormal gallbladder physiology (HP:0012438) | 2.36086442 |
69 | Fair hair (HP:0002286) | 2.36057185 |
70 | Neonatal hypoglycemia (HP:0001998) | 2.34841258 |
71 | Neonatal onset (HP:0003623) | 2.34076294 |
72 | Irritability (HP:0000737) | 2.33188812 |
73 | Gingival bleeding (HP:0000225) | 2.32039356 |
74 | Cardiovascular calcification (HP:0011915) | 2.28301716 |
75 | Malnutrition (HP:0004395) | 2.24598537 |
76 | Esophageal varix (HP:0002040) | 2.23164642 |
77 | Menorrhagia (HP:0000132) | 2.19995515 |
78 | Thrombophlebitis (HP:0004418) | 2.16084285 |
79 | Sensorimotor neuropathy (HP:0007141) | 2.12999246 |
80 | Pancreatitis (HP:0001733) | 2.12602162 |
81 | Late onset (HP:0003584) | 2.10067792 |
82 | Enlarged kidneys (HP:0000105) | 2.09937705 |
83 | Brushfield spots (HP:0001088) | 2.09366921 |
84 | Poikilocytosis (HP:0004447) | 2.05985066 |
85 | Reduced antithrombin III activity (HP:0001976) | 2.05816297 |
86 | Vomiting (HP:0002013) | 2.03515154 |
87 | Hemorrhage of the eye (HP:0011885) | 2.03379849 |
88 | Abnormality of the Achilles tendon (HP:0005109) | 2.01779441 |
89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01734839 |
90 | Arthropathy (HP:0003040) | 2.01719810 |
91 | Abnormality of the gallbladder (HP:0005264) | 2.01687353 |
92 | Opisthotonus (HP:0002179) | 2.00596865 |
93 | Generalized aminoaciduria (HP:0002909) | 1.97742910 |
94 | Joint swelling (HP:0001386) | 1.95800729 |
95 | Rickets (HP:0002748) | 1.92037853 |
96 | Abnormality of iron homeostasis (HP:0011031) | 1.90607104 |
97 | Elevated alkaline phosphatase (HP:0003155) | 1.89962612 |
98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87725022 |
99 | Hyperphosphaturia (HP:0003109) | 1.87241970 |
100 | Gangrene (HP:0100758) | 1.87167620 |
101 | Hypophosphatemic rickets (HP:0004912) | 1.85856957 |
102 | Abnormal cartilage morphology (HP:0002763) | 1.84804036 |
103 | Increased serum ferritin (HP:0003281) | 1.84076346 |
104 | Epistaxis (HP:0000421) | 1.83625313 |
105 | Bifid scrotum (HP:0000048) | 1.81593711 |
106 | Renal cortical cysts (HP:0000803) | 1.81123733 |
107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80956116 |
108 | Hydroxyprolinuria (HP:0003080) | 1.80693833 |
109 | Abnormality of proline metabolism (HP:0010907) | 1.80693833 |
110 | Elevated hepatic transaminases (HP:0002910) | 1.80573738 |
111 | Nephritis (HP:0000123) | 1.79932763 |
112 | Alkalosis (HP:0001948) | 1.78099967 |
113 | Status epilepticus (HP:0002133) | 1.78077317 |
114 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72858192 |
115 | Hyperglycemia (HP:0003074) | 1.72213057 |
116 | Abnormality of vitamin metabolism (HP:0100508) | 1.71445725 |
117 | Increased mean platelet volume (HP:0011877) | 1.71273448 |
118 | Abnormality of urine glucose concentration (HP:0011016) | 1.70857711 |
119 | Glycosuria (HP:0003076) | 1.70857711 |
120 | Cerebral palsy (HP:0100021) | 1.62920412 |
121 | Atrioventricular block (HP:0001678) | 1.61814035 |
122 | Generalized hypopigmentation of hair (HP:0011358) | 1.61406891 |
123 | Abnormal platelet volume (HP:0011876) | 1.54636304 |
124 | Abnormal delivery (HP:0001787) | 1.53073908 |
125 | Abnormal biliary tract physiology (HP:0012439) | 1.51565926 |
126 | Bile duct proliferation (HP:0001408) | 1.51565926 |
127 | Abnormal platelet function (HP:0011869) | 1.50609735 |
128 | Impaired platelet aggregation (HP:0003540) | 1.50609735 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.06996157 |
2 | FGFR4 | 4.71459140 |
3 | SIK1 | 4.58421449 |
4 | ERN1 | 4.45518126 |
5 | TAOK3 | 3.16398516 |
6 | INSRR | 3.02968842 |
7 | ERBB4 | 3.02824631 |
8 | MAP2K4 | 2.34166747 |
9 | PKN2 | 2.18124317 |
10 | MST1R | 2.11988547 |
11 | MAPK11 | 1.93094678 |
12 | FLT3 | 1.88547881 |
13 | NTRK3 | 1.83378244 |
14 | PRPF4B | 1.82356173 |
15 | PIK3CG | 1.82155945 |
16 | TRIB3 | 1.79039782 |
17 | TYK2 | 1.75752469 |
18 | LATS1 | 1.65165321 |
19 | DAPK2 | 1.56835865 |
20 | PTK6 | 1.50971439 |
21 | ABL2 | 1.46015713 |
22 | FGFR2 | 1.40265605 |
23 | NEK9 | 1.39965056 |
24 | FRK | 1.36299671 |
25 | KDR | 1.33591218 |
26 | PDK2 | 1.30843144 |
27 | JAK2 | 1.26228067 |
28 | NLK | 1.24984976 |
29 | MAP3K7 | 1.20176338 |
30 | TNK2 | 1.12777466 |
31 | PRKAA2 | 1.10732028 |
32 | PINK1 | 1.09459428 |
33 | ERBB2 | 1.07464124 |
34 | JAK1 | 1.06000968 |
35 | TBK1 | 1.05466301 |
36 | GRK6 | 1.05339658 |
37 | MAP2K3 | 1.03617266 |
38 | MAP3K10 | 1.00781961 |
39 | FER | 1.00378891 |
40 | MAPK4 | 0.98572845 |
41 | MAP3K14 | 0.96870830 |
42 | PRKG1 | 0.92665668 |
43 | PRKCZ | 0.91448016 |
44 | EPHB1 | 0.90248583 |
45 | MAPK15 | 0.87638834 |
46 | MET | 0.86770765 |
47 | EPHA3 | 0.85414789 |
48 | MAP3K2 | 0.83668015 |
49 | PRKACA | 0.82672986 |
50 | CAMKK2 | 0.82567023 |
51 | MAP3K3 | 0.81912331 |
52 | STK38L | 0.81184459 |
53 | CDK6 | 0.80184257 |
54 | MAPK12 | 0.79378201 |
55 | TIE1 | 0.77444324 |
56 | PRKACG | 0.76054845 |
57 | MAP3K11 | 0.75343954 |
58 | CAMK2G | 0.71842330 |
59 | DYRK1B | 0.70946137 |
60 | CAMK1D | 0.69409066 |
61 | CSK | 0.68917671 |
62 | GSK3A | 0.67083443 |
63 | PRKAA1 | 0.65734144 |
64 | CSNK1D | 0.63699074 |
65 | RIPK1 | 0.63338344 |
66 | MAP2K6 | 0.63181300 |
67 | SGK3 | 0.62830474 |
68 | FGFR3 | 0.61168503 |
69 | IRAK3 | 0.60987278 |
70 | ZAP70 | 0.60400803 |
71 | TGFBR2 | 0.58747777 |
72 | MAPK7 | 0.57878232 |
73 | CSF1R | 0.56607195 |
74 | PTK2 | 0.55830628 |
75 | PRKCB | 0.55656733 |
76 | RPS6KA3 | 0.55304217 |
77 | IKBKE | 0.54986455 |
78 | SGK1 | 0.53871307 |
79 | AKT3 | 0.51562081 |
80 | MYLK | 0.51349043 |
81 | PRKCQ | 0.51089736 |
82 | STK38 | 0.50727303 |
83 | CSNK1E | 0.50656370 |
84 | PDPK1 | 0.49329125 |
85 | CSNK1G1 | 0.48352738 |
86 | PRKACB | 0.47308501 |
87 | EPHA4 | 0.47258991 |
88 | SGK2 | 0.46185944 |
89 | PKN1 | 0.45157085 |
90 | SRC | 0.45066041 |
91 | BLK | 0.44967089 |
92 | CSNK2A1 | 0.44326321 |
93 | GRK1 | 0.44015747 |
94 | IGF1R | 0.43196756 |
95 | CAMKK1 | 0.43185622 |
96 | RET | 0.43074030 |
97 | MAP3K5 | 0.42382089 |
98 | MAPKAPK3 | 0.41927805 |
99 | MAP3K13 | 0.41637574 |
100 | TAOK2 | 0.41429916 |
101 | PRKCG | 0.40719231 |
102 | MAP2K1 | 0.40658181 |
103 | CDK4 | 0.39694517 |
104 | ICK | 0.37808233 |
105 | MTOR | 0.35890462 |
106 | MAP3K6 | 0.35846490 |
107 | CSNK2A2 | 0.35459716 |
108 | EGFR | 0.34635619 |
109 | WNK3 | 0.34317332 |
110 | MAPK3 | 0.33837676 |
111 | BRSK2 | 0.33829423 |
112 | PDGFRA | 0.33736154 |
113 | CAMK4 | 0.32450063 |
114 | SGK494 | 0.32073159 |
115 | SGK223 | 0.32073159 |
116 | PBK | 0.30952437 |
117 | PDK1 | 0.29500376 |
118 | MAP3K1 | 0.28488096 |
119 | CSNK1G2 | 0.27963967 |
120 | IRAK1 | 0.27462488 |
121 | PRKCA | 0.25230478 |
122 | CSNK1G3 | 0.25143056 |
123 | LATS2 | 0.24492183 |
124 | CAMK1G | 0.23518092 |
125 | IRAK2 | 0.23267785 |
126 | PAK3 | 0.21871220 |
127 | ABL1 | 0.21592987 |
128 | BMX | 0.20887010 |
129 | MAP2K2 | 0.19216031 |
130 | PIK3CA | 0.18504858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56369536 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68106405 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39240662 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33354223 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08861512 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.86623136 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67942767 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67777011 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63271799 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54785966 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47010547 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35953947 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22711042 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14146807 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10962881 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.06306007 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93156048 |
18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92897595 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90108926 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90025068 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90020694 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85671706 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83550022 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79358378 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76825434 |
26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75081085 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72205720 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69717981 |
29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69026498 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64633263 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60136567 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59516332 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55870935 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50604065 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50285905 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.49881139 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44680102 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34936452 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33682861 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31841706 |
41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31545567 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27475963 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22545803 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.21583358 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20170742 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19720499 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17035580 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11334975 |
49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02903053 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02882882 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98126533 |
52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97929989 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97642913 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94601183 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93995317 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86822801 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86304375 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83557525 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80273724 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77476766 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68710831 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65820254 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62433709 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56801567 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53224353 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45355484 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44994136 |
68 | Pertussis_Homo sapiens_hsa05133 | 0.39798528 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.39430457 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38770246 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25251447 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25072738 |
73 | Insulin resistance_Homo sapiens_hsa04931 | 0.23785722 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22555856 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22383939 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21449214 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20004183 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15657723 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09916866 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03378146 |
81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01805380 |
82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2394536 |
83 | Bladder cancer_Homo sapiens_hsa05219 | -0.2371573 |
84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2369029 |
85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2348591 |
86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2333570 |
87 | Amoebiasis_Homo sapiens_hsa05146 | -0.2307568 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2222233 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2217536 |
90 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2060700 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2053638 |
92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1932698 |
93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1894217 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1843686 |
95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1814641 |
96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1751913 |
97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1702728 |
98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1545001 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1516127 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1425101 |
101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1360197 |
102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1164041 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1012310 |
104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0835589 |
105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0752767 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0670339 |
107 | Mineral absorption_Homo sapiens_hsa04978 | -0.0643530 |
108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0589759 |
109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0532405 |